Evidence map›Paper›PMID 40019852›Full record

ArticleAmerican journal of respiratory cell and molecular biology2025

Elevated Senescence Markers in Developing Trisomy 21 Human Lungs.

Randa Belgacemi, Caroline Cherry, Michael Thompson, Maunick Koloko Ngassie, Anika Rehan, Imad El Alam, Claude Jourdan Le Saux, Ian Glass, Rodney D Britt, Y S Prakash and 3 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Senescence at the Crossroads of Lung Development and Injury.American journal of respiratory cell and molecular biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Randa BelgacemiThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.
Caroline CherryThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.
Michael ThompsonDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Maunick Koloko NgassieDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Anika RehanThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.
Imad El AlamThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.
Claude Jourdan Le SauxDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco, California.
Ian GlassUniversity of Washington School of Medicine, Seattle, Washington.
Rodney D BrittCenter for Perinatal Research, Nationwide Children's Hospital, Columbus, Ohio; and.ORCID 0000-0002-0027-9545
Y S PrakashDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Christina PabelickDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Soula DanopoulosThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.ORCID 0000-0002-2495-4445
Denise Al AlamThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California.ORCID 0000-0003-3148-7352

Funding

Type I IFN signaling during lung development in Down Syndrome-Multiome sequencing of human fetal and pediatric trisomy 21 lungsR01HL155104 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI DANOPOULOS, SOULA ATHANASIA · 2021 to 2025
$3.3M
Mechanisms controlling early human lung developmentR01HL141856 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI AL-ALAM, DENISE · 2018 to 2022
$2.5M
Cellular Senescence in Neonatal AirwaysR01HL158532 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S. · 2022 to 2025
$2.5M
Cellular Senescence in Trisomy 21 lung diseaseR01HL171915 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI Denise Al Alam, Christina Maria Pabelick · 2024 to 2026
$1.8M
Exploring the role of Hedgehog pathway-Primary cilia axis in human lung alveologenesis and diseaseK99HL177341 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI RANDA SONIA BELGACEMI · 2025 to 2026
$312k
National Institute of Child Health and Human Development R24HD000836NHLBI NIH HHS K99 HL177341NHLBI NIH HHS R01 HL141856NHLBI NIH HHS R01HL141856NHLBI NIH HHS R01 HL155104NHLBI NIH HHS R01 HL158532NHLBI NIH HHS R01 HL171915the California Institute for Regenerative Medicine EDUC4-12837
6 · The paper itself

Abstract

Human chromosomal anomalies, notably trisomies, disrupt gene expression, leading to diverse cellular and organ phenotypes. Increased cellular senescence (SEN) and oxidative stress in trisomies have gained recent attention. We assessed SEN, SEN-associated secretory phenotype (SASP), and oxidative stress on trisomy 13 (T13), T18, and T21 human fetal lung tissues and isolated primary human fetal lung fibroblasts. Telomerase-associated foci staining showed DNA damage primarily within T21 and T18 lungs. These results were confirmed by real-time quantitative PCR showing an increase of the SEN marker

Indexed as

Cellular SenescenceDown SyndromeLungBiomarkersDNA DamageFemaleFetusFibroblastsHistonesHumansInterleukin-6Oxidative StressReactive Oxygen SpeciesSenescence-Associated Secretory PhenotypeTelomeraseTrisomyBiomarkersH2AX protein, humanHistonesInterleukin-6Reactive Oxygen SpeciesTelomeraseDown syndromelung developmentsenescencetrisomy

Identifiers

PMID40019852
PMCPMC12334841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.